{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:08:56Z","timestamp":1790467736539,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T00:00:00Z","timestamp":1448323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/pds.3919","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T06:21:23Z","timestamp":1448432483000},"page":"170-178","source":"Crossref","is-referenced-by-count":33,"title":["Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies"],"prefix":"10.1002","volume":"25","author":[{"given":"Craig","family":"Hansen","sequence":"first","affiliation":[{"name":"Center for Clinical and Outcomes Research; Kaiser Permanente Georgia; Atlanta GA USA"},{"name":"South Australian Health and Medical Research Institute; Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Meyers Primary Care Institute; University of Massachusetts Medical School Worcester; Worcester MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Freiman","sequence":"additional","affiliation":[{"name":"Center for Clinical and Outcomes Research; Kaiser Permanente Georgia; Atlanta GA USA"},{"name":"Department of Medicine; Emory University School of Medicine; Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Dublin","sequence":"additional","affiliation":[{"name":"Group Health Research Institute; Seattle WA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Haffenreffer","sequence":"additional","affiliation":[{"name":"Department of Population Medicine; Harvard Medical School and Harvard Pilgrim Health Care Institute; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Vanderbilt University School of Medicine; Nashville TN USA"},{"name":"Department of Health Policy; Vanderbilt University School of Medicine; Nashville TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Craig","family":"Cheetham","sequence":"additional","affiliation":[{"name":"Pharmacy Analytical Services; Kaiser Permanente Southern California; Downey CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sengwee","family":"Toh","sequence":"additional","affiliation":[{"name":"Department of Population Medicine; Harvard Medical School and Harvard Pilgrim Health Care Institute; Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Kun","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Research; Kaiser Foundation Research Institute, Kaiser Permanente; Oakland CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha A.","family":"Raebel","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Colorado Institute for Health Research; Denver CO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Kuntz","sequence":"additional","affiliation":[{"name":"Center for Health Research; Kaiser Permanente Northwest; Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Perrin","sequence":"additional","affiliation":[{"name":"Center for Health Research; Kaiser Permanente Northwest; Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Gabriela","family":"Rosales","sequence":"additional","affiliation":[{"name":"Center for Health Research; Kaiser Permanente Northwest; Portland OR USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Carter","sequence":"additional","affiliation":[{"name":"LCF Research; Albuquerque NM USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamala A.","family":"Pawloski","sequence":"additional","affiliation":[{"name":"Health Partners Institute for Education and Research; Minneapolis MN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Maloney","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Graham","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Sahin","sequence":"additional","affiliation":[{"name":"Office of New Drugs; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela E.","family":"Scott","sequence":"additional","affiliation":[{"name":"Office of Women's Health; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yap","sequence":"additional","affiliation":[{"name":"Office of Biostatistics; Food and Drug Administration; Silver Spring MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Davis","sequence":"additional","affiliation":[{"name":"Center for Clinical and Outcomes Research; Kaiser Permanente Georgia; Atlanta GA USA"},{"name":"Center in Biomedical Informatics; University of Tennessee; Memphis TN USA"},{"name":"Department of Pediatrics; University of Tennessee; Memphis TN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"6","key":"10.1002\/pds.3919-BIB0001|pds3919-cit-0001","first-page":"853","article-title":"Urinary tract infections in pregnancy","volume":"54","author":"Lee","year":"2008","journal-title":"Can Fam Physician"},{"issue":"RR-4","key":"10.1002\/pds.3919-BIB0002|pds3919-cit-0002","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1002\/pds.3919-BIB0003|pds3919-cit-0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1002\/pds.3919-BIB0004|pds3919-cit-0004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1002\/pds.3919-BIB0005|pds3919-cit-0005","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pds.3495","article-title":"Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk","volume":"22","author":"Thorpe","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1002\/pds.3919-BIB0006|pds3919-cit-0006","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00016347309158319","article-title":"Trimethoprim-sulfonamide combination administered orally and intravaginally in the first trimester of pregnancy: its absorption into serum and transfer to amniotic fluid","volume":"52","author":"Ylikorkala","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"13","key":"10.1002\/pds.3919-BIB0007|pds3919-cit-0007","first-page":"67","article-title":"Maternal and transplacental kinetics of trimethoprim and sulfamethoxazole, separately and in combination","volume":"112","author":"Reid","year":"1975","journal-title":"Can Med Assoc J"},{"issue":"6","key":"10.1002\/pds.3919-BIB0008|pds3919-cit-0008","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0890-6238(01)00178-2","article-title":"The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study","volume":"15","author":"Czeizel","year":"2001","journal-title":"Reprod Toxicol"},{"issue":"22","key":"10.1002\/pds.3919-BIB0009|pds3919-cit-0009","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200011303432204","article-title":"Folic acid antagonists during pregnancy and the risk of birth defects","volume":"343","author":"Hernandez-Diaz","year":"2000","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1002\/pds.3919-BIB0010|pds3919-cit-0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hernandez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1002\/pds.3919-BIB0011|pds3919-cit-0011","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1365-2125.2009.03544.x","article-title":"Exposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations","volume":"68","author":"Matok","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1002\/pds.3919-BIB0012|pds3919-cit-0012","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0890-6238(90)90042-T","article-title":"A case-control analysis of the teratogenic effects of co-trimoxazole","volume":"4","author":"Czeizel","year":"1990","journal-title":"Reprod Toxicol"},{"issue":"1","key":"10.1002\/pds.3919-BIB0013|pds3919-cit-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jech.42.1.1","article-title":"Maternal drug histories and congenital malformations: limb reduction defects and oral clefts","volume":"42","author":"Hill","year":"1988","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"10.1002\/pds.3919-BIB0014|pds3919-cit-0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.reprotox.2005.01.008","article-title":"Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists","volume":"20","author":"Meijer","year":"2005","journal-title":"Reprod Toxicol"},{"issue":"11","key":"10.1002\/pds.3919-BIB0015|pds3919-cit-0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archpediatrics.2009.188","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"Crider","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"10.1002\/pds.3919-BIB0016|pds3919-cit-0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.2179","article-title":"Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study","volume":"21","author":"Molgaard-Nielsen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"10.1002\/pds.3919-BIB0017|pds3919-cit-0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1741-4520.2004.00012.x","article-title":"Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy","volume":"44","author":"Czeizel","year":"2004","journal-title":"Congenit Anom (Kyoto)"},{"key":"10.1002\/pds.3919-BIB0018|pds3919-cit-0018","volume-title":"Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk","author":"Briggs","year":"2008"},{"key":"10.1002\/pds.3919-BIB0019|pds3919-cit-0019","article-title":"Medication exposure in pregnancy risk evaluation program","author":"Andrade","year":"2011","journal-title":"Maternal Child Health Journal"},{"issue":"1","key":"10.1002\/pds.3919-BIB0020|pds3919-cit-0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pds.3319","article-title":"Validity of health plan and birth certificate data for pregnancy research","volume":"22","author":"Andrade","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1002\/pds.3919-BIB0021|pds3919-cit-0021","volume-title":"National Birth Defects Prevention Network (NBDPN). Guidelines for Conducting Birth Defects Surveillance","author":"Sever","year":"2004"},{"issue":"3","key":"10.1002\/pds.3919-BIB0022|pds3919-cit-0022","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/biomet\/75.3.501","article-title":"Conditional logistic regression models for correlated binary data","volume":"75","author":"Connolly","year":"1988","journal-title":"Biometrika"},{"key":"10.1002\/pds.3919-BIB0023|pds3919-cit-0023","volume-title":"Categorical Data Analysis Using the sas System","author":"Stokes","year":"2000"},{"key":"10.1002\/pds.3919-BIB0024|pds3919-cit-0024","volume-title":"Logistic Regression Using sas System: Theory and Application","author":"Allison","year":"1999"},{"issue":"6","key":"10.1002\/pds.3919-BIB0025|pds3919-cit-0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.0004-8666.2003.00127.x","article-title":"Findings on potential teratogens from a case-control study in Western Australia","volume":"43","author":"Werler","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1002\/pds.3919-BIB0026|pds3919-cit-0026","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdra.20749","article-title":"Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects","volume":"91","author":"Carter","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"10.1002\/pds.3919-BIB0027|pds3919-cit-0027","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/bdra.20460","article-title":"Maternal urinary tract infections and selected cardiovascular malformations","volume":"82","author":"Cleves","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"7658","key":"10.1002\/pds.3919-BIB0028|pds3919-cit-0028","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/bmj.39567.509074.25","article-title":"Case-control study of self reported genitourinary infections and risk of gastroschisis: findings from the national birth defects prevention study, 1997-2003","volume":"336","author":"Feldkamp","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/pds.3919-BIB0029|pds3919-cit-0029","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/14767050802488246","article-title":"Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?","volume":"22","author":"Mazor-Dray","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1002\/pds.3919-BIB0030|pds3919-cit-0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/00365540601087566","article-title":"Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments","volume":"39","author":"Banhidy","year":"2007","journal-title":"Scand J Infect Dis"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3919","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3919","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3919\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:25:05Z","timestamp":1625354705000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3919"}},"subtitle":["Sulfonamides and Risk of Congenital Anomalies"],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3919","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,24]]}}}